Elaine Ku

Credentials: · · · · · ·

History

Hypertension in CKD: Core Curriculum 2019
Review · American Journal of Kidney Diseases · 2019 · First of 4 authors · Corresponding · 393 citations
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International · 2023 · First of 14 authors · Corresponding · 109 citations
Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report
Review · American Journal of Kidney Diseases · 2018 · Last of 7 authors · 80 citations

Patient Provider Communication and Disparities in Access to Home Dialysis and Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.6M · University of California, San Francisco
2025–2030
Cardiovascular Risk Reduction in Adolescents and Young Adults with Kidney Disease
National Heart, Lung, and Blood Institute · K24
Contact PI · $378.3K · University of California, San Francisco
2024–2029
Racial Disparities in Access to Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $4.5M · University of California, San Francisco
2017–2029
Learners to LeAders in Benign Urology, Benign Nephrology, and Non-Cancer Hematology
National Institute of Diabetes and Digestive and Kidney Diseases · U2C
Contact PI · $3.2M · University of California, San Francisco
2023–2028

ACEi ARB Withdrawal in CKD Patients
Principal investigator · Withdrawn
University of California, San Francisco
2023
Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
Principal investigator · Withdrawn · Phase 2
University of California, San Francisco
2022–2023
Hypertension in Young Adults Trial
Principal investigator · Terminated · Phase 2
University of California, San Francisco
2022–2026
Watermelon/UBIQuinone Study
Principal investigator · Active not recruiting
University of California, San Francisco
2021–2026